Detalles de la búsqueda
1.
Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies-A Case-Control Study.
Int J Mol Sci
; 25(2)2024 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38255857
2.
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort.
Hepatology
; 76(1): 220-232, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34919289
3.
Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low-moderate liver fibrosis.
J Viral Hepat
; 27(11): 1214-1221, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32593212
4.
Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort.
Hepatology
; 66(6): 1814-1825, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28741307
5.
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?
Liver Int
; 38(12): 2190-2198, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29900654
6.
Protease inhibitors-based therapy induces acquired spherocytic-like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients.
Liver Int
; 36(1): 49-58, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26104535
7.
Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters.
Gut
; 64(2): 322-31, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24815676
8.
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort.
United European Gastroenterol J
; 12(3): 352-363, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38032175
9.
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and Delta cohort.
Int J Infect Dis
; : 107115, 2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38801968
10.
Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C.
Hepatology
; 56(5): 1641-50, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22610885
11.
Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia.
Intern Emerg Med
; 18(5): 1397-1404, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37212944
12.
The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study.
PLoS One
; 18(2): e0281813, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36795664
13.
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.
Hepatol Commun
; 7(11)2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37870985
14.
Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.
Hepatology
; 53(4): 1118-26, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21480318
15.
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience.
J Dig Dis
; 23(5-6): 324-330, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35700113
16.
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort.
Dig Liver Dis
; 53(12): 1603-1609, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33893040
17.
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort.
Hepatol Int
; 14(3): 362-372, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32279177
18.
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
PLoS One
; 13(1): e0190803, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29293676
19.
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
PLoS One
; 12(2): e0172159, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28245248
20.
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network.
PLoS One
; 12(10): e0185728, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28977040